211-225 of 813
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiersDevelopments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiersCaring for Women with MS: Key Considerations for Pregnancy and Menopause
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of SchizophreniaSchizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Steven Paul, MD
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiersDifferentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Maxwell H. Levy, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiersDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Steven Paul, MD
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiersNavigating Myasthenia Gravis in Adolescents and Young Adults
Jonathan Strober, MD
- advertisement
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
On the Frontlines of SchizophreniaQuality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Desiree Matthews, PMHNP-BC
Spotting the Signs: Early Identification and Management of Schizophrenia
On the Frontlines of SchizophreniaSpotting the Signs: Early Identification and Management of Schizophrenia
Desiree Matthews, PMHNP-BC
Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Spotlight On ATTR-CMSilent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiersRozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
NeuroFrontiersChallenges in DMD: Understanding the Height Factor
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of SchizophreniaSchizophrenia Care: Improving Social Cognition and Motivation
Michael Green, PhD
- advertisement
Henry Kaminski, MD
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiersFcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiersExamining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
